Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Noninvasive Earwax Test Aims to Detect Meniere’s Disease

By LabMedica International staff writers
Posted on 30 Sep 2026

Meniere’s disease is a chronic inner ear disorder that can cause vertigo, hearing loss, tinnitus, and a feeling of fullness in the ear. More...

Diagnosis can be difficult because symptoms overlap with other vestibular and auditory conditions. Current approaches rely heavily on clinical evaluation, patient history, and subjective symptom reporting, which may contribute to delayed or incorrect diagnosis. Researchers now describe an earwax-based method designed to support more objective detection.

The Research Foundation for the State University of New York (SUNY) has presented a technology for Meniere’s disease diagnosis from fatty acid levels in earwax. The approach uses mass spectrometry to analyze a small earwax sample from a patient. It is designed to identify biochemical markers associated with Meniere’s disease and compare measured molecular compounds with established disease-indicative profiles.

The method uses cerumen, or earwax, as a readily accessible biological sample for disease detection. By applying mass spectrometry, the system measures molecular compounds at a detailed chemical level. The goal is to detect subtle biochemical changes associated with Meniere’s disease, reducing reliance on symptom reporting, audiometric tests, and imaging methods that may be time-consuming or inconclusive.

The technology is described as a non-invasive, rapid, and potentially cost-effective approach for screening and diagnosis. It may also offer a way to monitor disease progression and response to treatment, according to the source description. Potential applications include early Meniere’s disease diagnosis, monitoring of disease progression, and screening of at-risk patient populations.

Current diagnostic approaches for Meniere’s disease lack widely accepted, non-invasive biomarker-based tests that can definitively confirm disease presence. The earwax mass spectrometry approach is positioned to address that gap by using an underutilized sample type for molecular-level assessment. The technology is patent pending and listed at technology readiness level 4.

Related Links
Research Foundation for the State University of New York


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Slide Scanner System
NanoZoomer S540MD
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.